
Two doses of the Pfizer-BioNTech COVID-19 vaccine is nearly 91% effective in preventing symptomatic illness in young children and brings no unexpected safety issues, according to a study posted Friday by the U.S. Food and Drug Administration. Late Friday, the agency posted its analysis of data from Pfizer’s pediatric study and said that in nearly… read on > read on >